Rapid model design in a browser, no login required.

Anthropic unveiled Claude Science on June 30, 2026, positioning the platform as its next major product after Claude Code — a purpose-built AI workbench that gives scientists a single environment for ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A researcher used Anthropic's new Claude Science tool to analyze 490 papers on zoonotic ...

Anthropic has launched Claude Science, an app that pulls a researcher’s scattered tools into one place and lets AI agents run large parts of the work. It is the company’s biggest push yet into the lab ...

AI startup Anthropic has launched Claude Science, a specialised workbench that has been built to help scientists quickly analyse complex data, manage heavy computer workflows and accelerate ...

Anthropic introduced Claude Science on Tuesday, an AI workbench that gives scientists one environment to do computational research, sparing them the hassle of bouncing between databases, pipelines, ...

Synthetic Sciences has released OpenScience, an open-source AI workbench for scientific research. It is licensed under Apache 2.0 and runs on your own infrastructure. The research team frames it as an ...

Use our currency converter to find the live exchange rate between CAD and USD. Convert Canadian Dollar to United States Dollar ...

USD/CAD attracts buyers for the second consecutive day amid a modest US Dollar strength. An uptick in Crude Oil prices could underpin the Loonie and cap further gains for spot prices. The technical ...

OpenScience is an AI workbench for scientific research. You give it a goal, and it works through the research loop the way a capable collaborator would. It reads the papers that matter, forms a ...

Thanks to the graphical user interface of Windows 10, users can get just about anything done by simply clicking on the icon. Without the GUI, we’d have been forced to do everything from the command ...

The AI drug boom has a long way to go before reaching patients. The AI drug boom has a long way to go before reaching patients. is a London-based reporter at The Verge covering all things AI and a ...